Hosted on MSN11mon
Boston Sci gets FDA approval for Agent in-stent restenosis balloon
Boston Scientific (NYSE:BSX) said it has received FDA approval for its Agent Drug-Coated Balloon for the treatment of coronary in-stent restenosis, the narrowing of a stented blood vessel due to ...
Hosted on MSN2d
If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...
Boston Scientific (NYSE:BSX) Price Target Raised to $115.00
Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Piper Sandler from $95.00 to $115.00 in a ...